BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24584348)

  • 21. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Founder Mutation in
    Dimishkovska M; Kotori VM; Gucev Z; Kocheva S; Polenakovic M; Plaseska-Karanfilska D
    Balkan Med J; 2018 Jan; 35(1):108-111. PubMed ID: 29400309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular defects identified by whole exome sequencing in a child with Fanconi anemia.
    Zheng Z; Geng J; Yao RE; Li C; Ying D; Shen Y; Ying L; Yu Y; Fu Q
    Gene; 2013 Nov; 530(2):295-300. PubMed ID: 23973728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
    Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
    Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The causes of Fanconi anemia in South Asia and the Middle East: A case series and review of the literature.
    Thompson AS; Saba N; McReynolds LJ; Munir S; Ahmed P; Sajjad S; Jones K; Yeager M; Donovan FX; Chandrasekharappa SC; Alter BP; Savage SA; Rehman S
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1693. PubMed ID: 33960719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.
    Tamary H; Dgany O; Toledano H; Shalev Z; Krasnov T; Shalmon L; Schechter T; Bercovich D; Attias D; Laor R; Koren A; Yaniv I
    Eur J Haematol; 2004 May; 72(5):330-5. PubMed ID: 15059067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study.
    Auerbach AD; Greenbaum J; Pujara K; Batish SD; Bitencourt MA; Kokemohr I; Schneider H; Lobitzc S; Pasquini R; Giampietro PF; Hanenberg H; Levran O;
    Hum Mutat; 2003 Feb; 21(2):158-68. PubMed ID: 12552564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
    van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
    Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies.
    Bogliolo M; Pujol R; Aza-Carmona M; Muñoz-Subirana N; Rodriguez-Santiago B; Casado JA; Rio P; Bauser C; Reina-Castillón J; Lopez-Sanchez M; Gonzalez-Quereda L; Gallano P; Catalá A; Ruiz-Llobet A; Badell I; Diaz-Heredia C; Hladun R; Senent L; Argiles B; Bergua Burgues JM; Bañez F; Arrizabalaga B; López Almaraz R; Lopez M; Figuera Á; Molinés A; Pérez de Soto I; Hernando I; Muñoz JA; Del Rosario Marin M; Balmaña J; Stjepanovic N; Carrasco E; Cuesta I; Cosuelo JM; Regueiro A; Moraleda Jimenez J; Galera-Miñarro AM; Rosiñol L; Carrió A; Beléndez-Bieler C; Escudero Soto A; Cela E; de la Mata G; Fernández-Delgado R; Garcia-Pardos MC; Sáez-Villaverde R; Barragaño M; Portugal R; Lendinez F; Hernadez I; Vagace JM; Tapia M; Nieto J; Garcia M; Gonzalez M; Vicho C; Galvez E; Valiente A; Antelo ML; Ancliff P; Garcia F; Dopazo J; Sevilla J; Paprotka T; Pérez-Jurado LA; Bueren J; Surralles J
    J Med Genet; 2020 Apr; 57(4):258-268. PubMed ID: 31586946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in
    Reyes P; García-de Teresa B; Juárez U; Pérez-Villatoro F; Fiesco-Roa MO; Rodríguez A; Molina B; Villarreal-Molina MT; Meléndez-Zajgla J; Carnevale A; Torres L; Frias S
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical aspects of Fanconi anemia individuals with the same mutation of FANCF identified by next generation sequencing.
    Nicchia E; Benedicenti F; De Rocco D; Greco C; Bottega R; Inzana F; Faleschini M; Bonin S; Cappelli E; Mogni M; Stanzial F; Svahn J; Dufour C; Savoia A
    Birth Defects Res A Clin Mol Teratol; 2015 Dec; 103(12):1003-10. PubMed ID: 26033879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families.
    Kimble DC; Lach FP; Gregg SQ; Donovan FX; Flynn EK; Kamat A; Young A; Vemulapalli M; Thomas JW; Mullikin JC; Auerbach AD; Smogorzewska A; Chandrasekharappa SC
    Hum Mutat; 2018 Feb; 39(2):237-254. PubMed ID: 29098742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.
    Huber PA; Medhurst AL; Youssoufian H; Mathew CG
    Biochem Biophys Res Commun; 2000 Feb; 268(1):73-7. PubMed ID: 10652215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of novel mutations of the major Fanconi anemia gene FANCA in the Japanese population.
    Yagasaki H; Hamanoue S; Oda T; Nakahata T; Asano S; Yamashita T
    Hum Mutat; 2004 Dec; 24(6):481-90. PubMed ID: 15523645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system.
    Reuter T; Herterich S; Bernhard O; Hoehn H; Gross HJ
    Blood; 2000 Jan; 95(2):719-20. PubMed ID: 10627486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
    Taniguchi T; D'Andrea AD
    Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
    Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.